WS #13312

From 500 msgs · 8 key-dev

AstraZeneca and Bristol Myers Squibb in preliminary $400B merger talks; Curium to acquire Lantheus for up to $114.50/share.

Pharma M&A: AstraZeneca-BMY and Curium-Lantheus

AstraZeneca and Bristol Myers Squibb in preliminary $400B merger talks; Curium to acquire Lantheus for up to $114.50/share.

Full world state #13312 →